Healthcare -
Biotechnology - NASDAQ - US
$ 40.76
-11 %
$ 3.21 B
Market Cap
-7.65
P/E
PTCT - REVENUE
Revenue PTCT - PTC Therapeutics, Inc.
807 M
LAST VALUE
7.45%
2 YEAR CAGR
21.32%
5 YEAR CAGR
42.75%
10 YEAR CAGR